RTTNews | Jul 1, 2021 06:10AM EDT

06:09 Thursday, July 1, 2021 (RTTNews) - FDA Accepts Filing Of HUTCHMED's Surufatinib NDA For Pancreatic And Extra-pancreatic Neuroendocrine Tumors

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved